Evidence map›Paper›PMID 21495259›Full record

ReviewTopics in current chemistry2010

Total (bio)synthesis: strategies of nature and of chemists.

Alexandra A Roberts, Katherine S Ryan, Bradley S Moore, Tobias A M Gulder

Abstract readComparative StudyReview
In one paragraph

Review in Topics in current chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Total synthesis: an enabling science.Beilstein journal of organic chemistry · 2023
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Quo vadis, enzymology?Nature chemical biology · 2015
    Article
  11. One-pot enzymatic synthesis of merochlorin A and B.Angewandte Chemie (International ed. in English) · 2014
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexandra A RobertsCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, La Jolla, CA 92093, USA.
Katherine S Ryan
Bradley S Moore
Tobias A M Gulder

Funding

Natural Product Genome MiningR01GM085770 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JENSEN, PAUL R, MOORE, BRADLEY S · 2009 to 2024
$5.8M
ENGINEERING DIVERSITY WITH ENTEROCIN BIOSYNTHESIS GENER01AI047818 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MOORE, BRADLEY S · 2000 to 2022
$5.2M
Type III Polyketide Synthases: Structure and MechanismR56AI047818 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MOORE, BRADLEY S · 2005 to 2017
$565k
Howard Hughes Medical InstituteNIAID NIH HHS AI47818NIAID NIH HHS R01 AI047818NIAID NIH HHS R56 AI047818NIGMS NIH HHS GM85770NIGMS NIH HHS R01 GM085770
6 · The paper itself

Abstract

The biosynthetic pathways to a number of natural products have been reconstituted in vitro using purified enzymes. Many of these molecules have also been synthesized by organic chemists. Here we compare the strategies used by nature and by chemists to reveal the underlying logic and success of each total synthetic approach for some exemplary molecules with diverse biosynthetic origins.

Indexed as

AlkaloidsBacteriaBiological ProductsBiomimeticsPhenazinesPlantsSesquiterpenesSiderophoresAlkaloidsBiological ProductsPhenazinesSesquiterpenesSiderophores

Identifiers

PMID21495259
PMCPMC3109256

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.